Literature DB >> 19490983

Estimation of vaccine efficacy against acquisition of pneumococcal carriage.

Hanna Rinta-Kokko1, Ron Dagan, Noga Givon-Lavi, Kari Auranen.   

Abstract

Evaluation of the effect of new conjugate vaccines on nasopharyngeal carriage of Streptococcus pneumoniae (pneumococcus) has been based on simple comparisons of the prevalence of carriage in vaccinees and controls. However, the definition and measurement of vaccine efficacy should be based on knowledge of the actual mechanism of the vaccine's effect. According to current knowledge, conjugate vaccines affect acquisition. We propose a simple-to-use method to measure vaccine efficacy against serotype-specific acquisition that needs only cross-sectional measurements of carriage. We demonstrate the use of the method by application to a data set where it is also possible to estimate efficacy against acquisition from longitudinal measurements.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19490983     DOI: 10.1016/j.vaccine.2009.04.009

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  33 in total

1.  Serological criteria and carriage measurement for evaluation of new pneumococcal vaccines.

Authors:  Nicola Principi; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Estimating rates of carriage acquisition and clearance and competitive ability for pneumococcal serotypes in Kenya with a Markov transition model.

Authors:  Marc Lipsitch; Osman Abdullahi; Alexander DʼAmour; Wen Xie; Daniel M Weinberger; Eric Tchetgen Tchetgen; J Anthony G Scott
Journal:  Epidemiology       Date:  2012-07       Impact factor: 4.822

3.  Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes.

Authors:  Sarah Cobey; Marc Lipsitch
Journal:  Science       Date:  2012-03-01       Impact factor: 47.728

4.  Using pneumococcal carriage data to monitor postvaccination changes in invasive disease.

Authors:  Daniel M Weinberger; Dana T Bruden; Lindsay R Grant; Marc Lipsitch; Katherine L O'Brien; Stephen I Pelton; Elisabeth A M Sanders; Daniel R Feikin
Journal:  Am J Epidemiol       Date:  2013-09-07       Impact factor: 4.897

5.  Prevalence of Heptavalent Vaccine-related Pneumococcal Serotypes in Nasopharyngeal carrier in children under five years old in Shahrekord, Iran by Multiplex-PCR during 2010- 2011.

Authors:  Abolfazl Khoshdel; Reza Imani Rastabi; Abbas Doosti; Shahin Askari; Masoud Hafizi
Journal:  J Clin Diagn Res       Date:  2014-11-20

6.  Uses of pathogen detection data to estimate vaccine direct effects in case-control studies.

Authors:  Joseph A Lewnard
Journal:  J R Soc Interface       Date:  2020-08-12       Impact factor: 4.118

Review 7.  Postexposure Effects of Vaccines on Infectious Diseases.

Authors:  Tara Gallagher; Marc Lipsitch
Journal:  Epidemiol Rev       Date:  2019-01-31       Impact factor: 6.222

8.  Streptococcus pneumoniae oropharyngeal colonization in school-age children and adolescents with type 1 diabetes mellitus: Impact of the heptavalent pneumococcal conjugate vaccine.

Authors:  Nicola Principi; Lorenzo Iughetti; Marco Cappa; Claudio Maffeis; Franco Chiarelli; Gianni Bona; Monia Gambino; Luca Ruggiero; Viviana Patianna; Maria Cristina Matteoli; Marco Marigliano; Paola Cipriano; Silvia Parlamento; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2015-11-17       Impact factor: 3.452

9.  Estimating strain-specific and overall efficacy of polyvalent vaccines against recurrent pathogens from a cross-sectional study.

Authors:  Kari Auranen; Hanna Rinta-Kokko; M Elizabeth Halloran
Journal:  Biometrics       Date:  2013-02-04       Impact factor: 2.571

10.  Outbreaks of Streptococcus pneumoniae carriage in day care cohorts in Finland - implications for elimination of transmission.

Authors:  Fabian Hoti; Panu Erästö; Tuija Leino; Kari Auranen
Journal:  BMC Infect Dis       Date:  2009-06-27       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.